Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Akers Biosciences gains US patent for disposable cartridge

Thu, 16th Feb 2017 08:44

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers.The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's BreathScan Lync technology, a new bluetooth-enabled reading device from Akers Wellness which allows users to track the results of breath-based tests on their mobile.The patent covers the design of the disposable cartridge which contains the reagent for the detection of wellness markers and the unique form factor, optical lens as well as read elements and the unique 'U' shaped airflow pathway.Chief executive John J. Gormally said: "We believe Akers Bio's technology for rapidly analyzing biomarkers in breath condensate is ideally suited for tests in the expansive US health and wellness market. I am pleased that this latest patent has been allowed as it is essential that we have robust protection over our valuable intellectual property."Separately, the AIM-listed company said that it is ramping marketing for OxiChek, a disposable breath test to determine levels of oxidative stress in the body by measuring the levels of certain abundant free radicals, through its distributor Aero-Med to anti-aging, functional and integrative health and wellness treatment practitioners in the US.Akers Wellness is also in talks with potential distributors for the KetoChek test which determines if a person is in the optimal fat-burning state for weight loss, known as ketosis.Gormally said: "OxiChek is the first fully commercialized Akers Wellness test in which this cartridge is applied. We are pleased that initial sales of this test are being recorded and excited about the scope for ramping up sales through national television marketing initiatives and major tradeshow participation."
More News
4 Nov 2014 16:15

UK AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

Read more
4 Nov 2014 06:13

UK AGM, EGM Calendar - Week Ahead

Read more
3 Nov 2014 16:09

UK AGM, EGM Calendar - Week Ahead

Read more
23 Oct 2014 12:30

Akers Biosciences Inks Joint Venture Deal With Hainin Savy In China

Read more
9 Sep 2014 16:02

MARKET COMMENT: London Ends Mixed Amid Boost From Production Data

Read more
9 Sep 2014 11:46

Akers Biosciences Signs USD864,000 Tri-Cholesterol "Check" Sales Deal

Read more
15 Aug 2014 07:39

UK MORNING BRIEFING: Miners Lead Broad-Based London Gains

Read more
15 Aug 2014 06:46

Akers Biosciences Appoints Co-Chairman

Read more
12 Aug 2014 10:42

Akers Biosciences Posts Wider Loss But Rise In Flagship Product Sales

Read more
28 Jul 2014 10:20

Akers Inks Feasibility Study Deal With Konica For Heart Attack Tests

Read more
17 Jul 2014 10:18

Akers Biosciences Breath Device Granted Patent

Read more
25 Jun 2014 13:28

REPEAT: Akers Biosciences Inks Distribution Agreement With Medline Industries

Read more
25 Jun 2014 12:40

UK MIDDAY BRIEFING: AbbVie Sets Out Case For Shire Acquisition

Read more
25 Jun 2014 12:10

Akers Biosciences secures US distribution for heparin test

Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin. The company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries, which it said was

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.